←Back to Expert Scholars
Translational Medicine / 转化医学Head and Neck Cancer
Ezra Cohen
MD
🏢Tempus Labs🌐USA
Chief Medical Officer, Oncology
105
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ezra Cohen led CheckMate-141 establishing nivolumab as a second-line standard for recurrent metastatic HNSCC and has shaped immunotherapy development across head and neck cancer. He now leads oncology clinical programs at Tempus Labs.
Share:
🧪Research Fields 研究领域
nivolumab head and neck
CheckMate-141
head and neck immunotherapy
precision oncology
biomarkers HNSCC
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ezra Cohen 的研究动态
Follow Ezra Cohen's research updates
留下邮箱，当我们发布与 Ezra Cohen（Tempus Labs）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment